Oct 17
|
Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans?
|
Oct 17
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
Oct 17
|
Novavax Stock Falls After FDA Puts Two Vaccine Programs on Hold
|
Oct 16
|
GSK claims Moderna infringed mRNA vaccine patents
|
Oct 16
|
Why I'm Considering Leaning Heavily Into Pfizer
|
Oct 15
|
Viatris Settles Lawsuit, Avoids Antitrust Charges, and Advances Effexor Study
|
Oct 15
|
Walgreens closing 1,200 stores over next 3 years, 800 more under evaluation
|
Oct 15
|
This is the 3-point checklist for healthcare earnings: Strategist
|
Oct 15
|
Pfizer taps Vanguard veteran for board amid fight with Starboard
|
Oct 15
|
Nvidia's 84% Expected Profit Growth Looms Large In S&P 500
|
Oct 15
|
Johnson & Johnson (JNJ) Tops Q3 Earnings and Revenue Estimates
|
Oct 15
|
Pfizer invests in molecular glue; Jazz, MeiraGTx shares rise on drug data
|
Oct 15
|
Tim Buckley Elected to Pfizer’s Board of Directors
|
Oct 15
|
Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?
|
Oct 15
|
2 Ultra-High-Yield Dividend Stocks With Total Return Potential of Up to 92% in 12 Months, According to Select Wall Street Analysts
|
Oct 14
|
Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note
|
Oct 14
|
How to play biotech stocks: Johnson & Johnson, Pfizer
|
Oct 14
|
Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade
|
Oct 14
|
Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?
|
Oct 14
|
Pfizer Secures FDA Approval for Hemophilia Drug Hympavzi
|